Annals of African Medicine
Home About AAM Editorial board Ahead of print Current Issue Archives Instructions Subscribe Contact us Search Login 


 
Table of Contents
LETTER TO EDITOR
Year : 2017  |  Volume : 16  |  Issue : 3  |  Page : 148  

Atherogenic index of plasma for the assessment of cardiovascular risk factors


1 Sanitation1 Medical Academic Center, Bangkok, Thailand
2 Tropical Medicine, Hainan Medical University, Haikou, China

Date of Web Publication28-Jun-2017

Correspondence Address:
Beuy Joob
Sanitation1 Medical Academic Center, Bangkok
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aam.aam_332_16

Rights and Permissions

How to cite this article:
Joob B, Wiwanitkit V. Atherogenic index of plasma for the assessment of cardiovascular risk factors. Ann Afr Med 2017;16:148

How to cite this URL:
Joob B, Wiwanitkit V. Atherogenic index of plasma for the assessment of cardiovascular risk factors. Ann Afr Med [serial online] 2017 [cited 2020 Oct 28];16:148. Available from: https://www.annalsafrmed.org/text.asp?2017/16/3/148/209084

Sir,

We read the recent publication on “Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria” with a great interest.[1] Olamoyegun et al. concluded that “serum lipid ratios and atherogenic index of plasma (AIP) may be used in addition to lipid parameters in clinical practice to assess cardiovascular risks even when lipid profiles are apparently normal.” We agree that AIP can be useful in clinical practice, but there are some concerns on using this parameter. First, the calculation of the AIP is difficult and this will not be user-friendly for general practitioner. This might be the reason why the parameter is not widely used in clinical practice. Second, if the baseline low-density lipoprotein is derived by calculation, the problem of accuracy can be expected in case that the calculation has limitation.[2] As noted by Marniemi et al., “in hypertriglyceridemic subjects, the calculation formulas probably should not be used at all.”[3] Nevertheless, the problem on imprecision of the AIP is also the important concern in laboratory medicine.[3]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Olamoyegun MA, Oluyombo R, Asaolu SO. Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria. Ann Afr Med 2016;15:194-9.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Marniemi J, Mäki J, Maatela J, Järvisalo J, Impivaara O. Poor applicability of the Friedewald formula in the assessment of serum LDL cholesterol for clinical purposes. Clin Biochem 1995;28:285-9.  Back to cited text no. 2
    
3.
Holmes DT, Frohlich J, Buhr KA. The concept of precision extended to the atherogenic index of plasma. Clin Biochem 2008;41:631-5.  Back to cited text no. 3
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed1840    
    Printed30    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal